Do we need to adjust for interim analyses in a Bayesian adaptive trial design? (2020)
Attributed to:
Evaluation of Bayesian adaptive designs for Phase 3 effectiveness trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12874-020-01042-7
PubMed Identifier: 32522284
Publication URI: http://europepmc.org/abstract/MED/32522284
Type: Journal Article/Review
Volume: 20
Parent Publication: BMC medical research methodology
Issue: 1
ISSN: 1471-2288